PrimeRFP SCOUT · Federal Contract Recompete Brief

W81K0223P0026Reagents to include chemistry immunology — Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch

Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch holds $2.4M across 8 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 1 related award in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: Unrestricted. Recompete timing centers on the Sep 30, 2026 PoP end — agencies typically plan 12–18 months ahead.

W40m Rhco Pacific

Awarding office

Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch

Recipient

Sep 30, 2026

PoP end

$2M

Obligated

$2.5M

Potential

325413

NAICS

6515

PSC

Unrestricted

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted

Contract numberW81K0223P0026

Also listed asW81K02-23-P-0026

AgencyW40m Rhco Pacific

Awarding officeW40m Rhco Pacific

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentOrtho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch

CAGE767DF

UEIJNSJRDQQH2J6

NAICS325413

No full NAICS 325413 intel page yet. Browse NAICS intelligence

PSC6515

Pricing typeFirm Fixed Price

Extent competedCompeted Under SAP

Related solicitationW81K0223Q0004

PoP startJul 1, 2023

PoP end (current)Sep 30, 2026

PoP end (w/ options)Sep 30, 2027

Obligated$2M

Current value$2M

Potential value$2.5M

REAGENTS TO INCLUDE CHEMISTRY/IMMUNOLOGY ANALYZERS FOR BRAIN D. ALLGOOD ARMY COMMUNITY HOSPITAL, KOREA. is a federal Unrestricted award for W40m Rhco Pacific held by Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch. Estimated value $2.5M ($2M obligated). Current period of performance ends Sep 30, 2026 (potential Sep 30, 2027). Last award drew 1 bidder. Related solicitation W81K0223Q0004.

REAGENTS TO INCLUDE CHEMISTRY/IMMUNOLOGY ANALYZERS FOR BRAIN D. ALLGOOD ARMY COMMUNITY HOSPITAL, KOREA.

Recompete timing

Public

● Expiring in 3 days

Current PoP ends Sep 30, 2026 (3 days remaining). Agencies typically plan 12–18 months ahead — at 0.1 months out, that window is already open. The buying decision is likely already in motion.

Bonuses end Sept 30

Want the durability read on W81K0223P0026? One Pursuit Analysis, $500, inside 48 business hours.

48 business hours
$500
Credits toward the Pack

Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch — $2.4M obligated across 8 awards (firm-wide, all agencies).

Sole agency: Department of Defense (DOD)

Department of Defense (DOD)$2.4M · 100% of firm total

Open full company profile →

Related awards

Same incumbent

W81K0225FA115

VITROS XT7600 REAGENTS FOR 51ST MDG, OSAN KOREA

$233K

Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract W81K0223P0026?

W81K0223P0026 (Reagents to include chemistry immunology) is a W40m Rhco Pacific award with a potential value of $2.5M, currently held by Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is W81K02-23-P-0026?

W81K02-23-P-0026 is the dashed form of PIID W81K0223P0026 (Reagents to include chemistry immunology), held by Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded W81K0223P0026?

W40m Rhco Pacific awarded W81K0223P0026 to Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch (potential $2.5M).

Who is the incumbent on W81K0223P0026?

Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch is the incumbent with $2.4M across 8 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.

When does Ortho-Clinical Diagnostics Singapore Pte. Ltd.. Korea Branch’s W81K0223P0026 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on W81K0223P0026? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 24, 2026 · refreshed monthlyLatest procurement action May 7, 2026